Michigan Company ready for Phase 3 clinical trial for critical

Jeannine

Pioneer Founding member
Aastrom Biosciences ready for stem cell clinical trial for critical limb ischemia
By Tom Henderson


Ann Arbor-based Aastrom Biosciences Inc. (Nasdaq: ASTM) announced Wednesday that based on encouraging results from a Phase 2b clinical study of 46 patients with a condition known as critical limb ischemia, patients will be enrolled in a follow-up Phase 3 study of a stem cell-based therapy known as Restore-CLI.

Critical limb ischemia is the end stage of peripheral arterial disease, and patients with it face a high risk of amputation. Approximately one million patients in the U.S. suffer from the disease, with more than 160,000 amputations each year.

The results showed the therapy was as safe as treatment with a placebo and was more effective in controlling wound size and gangrene and delaying amputation.

?We look forward to presentation of the full data at an appropriate medical meeting,? said CEO and President Tim Mayleben of the Phase 2b results in a press release, ?and initiating the next phase of testing as soon as possible.?

http://www.crainsdetroit.com/article/20100224/GEO01/100229927#
 
thank you

Thank you janine,
I ask for trial in nepsis for hearing loss?

Is it free?
And how may i apply for it? The site is out of order at present
thank you
Eli italy
 

barbara

Pioneer Founding member
Nepsis is undergoing a name change and a website change. Their site should be available soon. Approved FDA clinicals in the U.S. do not require that a patient pays. Private clinicals may or may not depending on the resources of the company involved. Very few stem cell clinics have the funding and resources needed to conduct clinicals without asking the patients to help pay for them, Nepsis included. The cost of conducting years worth of clinicals is out of reach for most except if they have ties to a pharmaceutical company with big bucks or happen to get lucky enough to get a major grant for their work.
 
Top